Navigation Links
Stem cells - New and richer source found

A recent study by researchers at Kansas State University has found that Wharton's jelly, the cushioning material or matrix within the umbilical cord, is a rich and readily available source of primitive stem cells. These umbilical cord matrix cells, which show tell-tale characteristics of all stem cells, could provide the scientific and medical research community with a non-controversial and easily attainable source of stem cells for developing treatments for Parkinson’s disease, stroke, spinal// cord injuries, cancers and other condition.

The development of many embryonic stem cell-based therapies for treating several degenerative diseases of the nervous system as well as other types of disease is hindered by the controversial nature of the cell sources. The cord matrix cells - called so, to distinguish them from cord blood cells - can be obtained in the non-invasive manner from an abundant source of tissue that is typically discarded. Researchers point out that Wharton's jelly might be a reservoir of the primitive stem cells that form soon after the egg is fertilized. Wharton’s jelly is the gelatinous connective tissue only found in the umbilical cord. The jelly gives the cord resiliency and pliability, and protects the blood vessels in the umbilical cord from compression.

The researchers propagated Wharton’s jelly cells from pigs in the lab without losing potency. The encouraging results with the animal tissue, prompted the team of researchers to broaden their investigations to human umbilical cord matrix cells, which also produced similar exciting findings - human umbilical cord matrix cells also differentiated into neurons.

'"/>




Page: 1

Related medicine news :

1. Action of nerve cells
2. Therapy for stopping the spread of cancer cells
3. Hydroxyurea derivatives kill colon cancer cells
4. Creating brain cells from bone marrow
5. A Chinese herb kills cancer cells
6. Immune cells halt round in space
7. Transforming stem cells to lung cells
8. Changing stem cells to liver cells
9. Enzyme stimulates growth of adult stem cells
10. Stem cells aid to cure brain cancer
11. Brain cells protected by new compounds
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Stem cells New and richer source found

(Date:7/25/2008)... reduces lung function, increases asthma risk, stu...hDay News) -- A clean, fresh-smelling home may act...pe of cleaning and air freshening products you use...leaning products or air fresheners that contain a ... dicholorobenzene (1,4 DCB), can reduce lung funct...
(Date:7/25/2008)... -- BeaconEquity.com announces the,availability of...tors can view all of the daily trading notes for f...ay,s Trade Alerts include: DUSA Pharmaceuticals In...nc. (Nasdaq: MBRK ), NovaMed Inc. (Nasdaq:,NOVA),...asdaq: AFFX ) and,Abaxis Inc. (Nasdaq: ABAX )., ...
(Date:7/25/2008)...rketing Exclusivity Begins -, CORONA, Calif., Jul...als, Inc. (NYSE: WPI ), a leading specialty pharm...iary has commenced commercial,shipment of its Omep... 40mg,strength from its Davie, Florida manufacturi...n has 180 days of marketing exclusivity for being ...
(Date:7/25/2008).../ -- The Elekta Family of Companies will,showcase ... the 2008,American Association of Physicists in Me...e joint forces of Elekta, IMPAC and CMS are delive...elivery solutions that,streamline the treatment pr...as well as enhance clinician efficiency., "Our re...
Breaking Medicine News(10 mins):Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3
...breathing problems in current cigarette smokers wi...ccording to a study presented at the American Tho... study found that among people 40 and older, smoke...ely as nonsmokers to develop COPD, while smoking c...
...mors appear to respond favorably to the drug temoz...rgery, and the treatment appears to work best in ...shed in the scientific journal of the American Aca...ied 149 people with low grade gliomas, a slow-grow...
...rchers from Wake Forest University School of Medic...ght throughout adulthood may help prevent or dela...study found that older adults with a history of ex...d worse physical performance than those who were n...
... found that vegetarian diet reduces risk of colon ...up as appetizer reduces food intake by about 20 pe...tors like choosing your diet regimen or ordering a...r for dinner may help in managing a healthy lifest...
Other Medicine News:Health News:Marijuana Worsens Breathing Problems in Current Smokers 2Health News:Maintaining a Healthy Lifestyle During Adulthood may Delay Old Age Disability 2Health News:Vegetarian Diet Could Reduce Risk of Colon Cancer 2Health News:Vegetarian Diet Could Reduce Risk of Colon Cancer 3Health News:Vegetarian Diet Could Reduce Risk of Colon Cancer 4
(Date:7/23/2008)...ound Pharmaceuticals (SPI) has filed,an Investigat...inical,testing of a proprietary formulation of ebs...aring loss or ototoxicity. The oral capsule,contai... stage lung cancer,and head and neck cancer patien...ks the second development program for SPI to enter...
(Date:7/23/2008)...Call/ -- Dendreon Corporation,(Nasdaq: DNDN ) tod...Monitoring Committee (IDMC) to review in October 2...ing to the Company,s Phase 3 IMPACT (IMmunotherapy... as D9902B) clinical trial,of PROVENGE(R) (sipuleu...active cellular immunotherapy for the treatment of...
(Date:7/22/2008)...evelopment Initiative bring MJFF,s,current active ...ry 20,2009, NEW YORK, July 22 /PRNewswire-USNews...of transformative treatments and a cure for Parkin...arkinson,s Research has awarded,$2.7 million in to...ards,were granted under MJFF,s Therapeutics Develo...
(Date:7/22/2008)...Importance to Patients of Passing a ..., Va., July 22 /- Insmed In...ogics and biopharmaceuticals, today,announced that...t at a,Congressional briefing on Friday, July 25th...shing an approval pathway for follow-on,biologics ...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Survey Finds U S Healthcare Facilities Not Doing Enough to Curb MRSA 1044 1Survey Finds U S Healthcare Facilities Not Doing Enough to Curb MRSA 1044 2Survey Finds U S Healthcare Facilities Not Doing Enough to Curb MRSA 1044 3EntreMed Announces FDA Acceptance of IND Application for Panzem 28R 29 in Rheumatoid Arthritis 8090 1EntreMed Announces FDA Acceptance of IND Application for Panzem 28R 29 in Rheumatoid Arthritis 8090 2EntreMed Announces FDA Acceptance of IND Application for Panzem 28R 29 in Rheumatoid Arthritis 8090 3EntreMed Announces FDA Acceptance of IND Application for Panzem 28R 29 in Rheumatoid Arthritis 8090 4Rand study examines the effect of policy on entrepreneurship and small businesses 8089 1Rand study examines the effect of policy on entrepreneurship and small businesses 8089 2Ames Laboratory researchers solve fuel cell membrane structure conundrum 2140 1Ames Laboratory researchers solve fuel cell membrane structure conundrum 2140 2
...Genentech and FDA notified,healthcare professional...acheoesophageal (TE) fistula formation in a recent...ll cell lung,cancer (SCLC). This multicenter, non-...dy combined chemotherapy and radiation plus,Avasti...vents of TE,fistula (one fatal) reported in the fi...
...mence shortly, CARMIEL, Israel, April 18, 2007 /PR...Inc. today announced that it has received,written ...stration,(FDA) that it may initiate a Phase III cl...uct candidate, prGCD, a proprietary plant,cell exp...e (GCD),for the treatment of Gaucher Disease, a l...
Other Medicine Technology:Protalix BioTherapeutics, Inc. Receives Approval from the FDA to,Initiate a Phase III Clinical Trial of prGCD 2Protalix BioTherapeutics, Inc. Receives Approval from the FDA to,Initiate a Phase III Clinical Trial of prGCD 3
Craniosorb Absorbable Fixation System (AFS) is uniquely designed to offer simple and reproducible fixation of the cranial flap and allow for complete absorption of the plating system over time.
1.7/2.2 mm Delta System resorbable implant technology merges science and simplicity for a superior craniomaxillofacial surgery product. The system consists of resorbable bone plates and screws fabric
By combining intra-operative ultrasound imaging with preoperative imagery, Medtronic Surgical Navigation Technologies has created a revolutionary product called SonoNav Intra-operative Imaging System
...oglue) is a two-component surgical adhesive compos...araldehyde. The BSA is obtained from cattle exclus...free countries and undergoes processing that reduc...nsed by a controlled delivery system, composed of ...
Medicine Products: